Ropes & Gray represented 1440 Foods in the transaction, and Finn Dixon & Herling represented FITCRUNCH and Bakery Barn. 1440 Foods, a portfolio of sports and...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Monte Rosa Therapeutics on the transaction. Monte Rosa Therapeutics (Nasdaq: GLUE) has entered into a global exclusive licensing agreement with Novartis to...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Adaptimmune Therapeutics on the transaction. Adaptimmune Therapeutics (NASDAQ: ADAP) announced it has entered into a clinical collaboration agreement with Galapagos NV (Euronext...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Adaptimmune Therapeutics plc on the transaction, and DLA Piper advised Hercules Capital. Adaptimmune Therapeutics plc (NASDAQ: ADAP), a clinical-stage biopharmaceutical company, announced...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Dessert Holdings in the transaction, and Holland & Knight represented Kenny’s Great Pies. Dessert Holdings®, North America’s premium dessert company, announced that...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Novavax Inc. in the transaction. Novavax Inc.(Nasdaq: NVAX) announced it has entered into a co-exclusive licensing agreement with French pharmaceutical company Sanofi...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz served as legal advisor to AbbVie, while Ropes & Gray served as legal advisor to ImmunoGen. AbbVie Inc. (NYSE: ABBV) and...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised MACOM on the deal, and Smith Anderson advised Wolfspeed. MACOM Technology Solutions Holdings, Inc. (NASDAQ: MTSI) announced that it has entered into a...
You must be a Standard 1 Year member to access this content.
Goodwin advised TCR² Therapeutics Inc. on the deal while Ropes & Gray represented Adaptimmune Therapeutics plc. TCR² Therapeutics Inc. (NASDAQ: TCRR) announced its definitive agreement with Adaptimmune...
You must be a Standard 1 Year member to access this content.
Pillsbury Winthrop Shaw Pittman LLP advised NEUCA Group on the deal while Ropes & Gray advised Moffitt Cancer Center and OncoBay Clinical. NEUCA Group, the parent...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented CANbridge Pharmaceuticals on the deal. CANbridge Pharmaceuticals, a China-based biopharmaceutical company, announced its exclusive worldwide license agreement with UMass Chan Medical School relating...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Moffitt Cancer Center and OncoBay Clinical on the deal. OncoBay obtained an investment from Clinscience, a global clinical research organization based in Warsaw,...
You must be a Standard 1 Year member to access this content.
